Actively Recruiting
Effect of the Postbiotics on Complications Treatment in Elderly Hemodialysis Patients
Led by Peking University First Hospital · Updated on 2025-05-16
60
Participants Needed
1
Research Sites
121 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of the trial is to explore the effect of exogenous postbiotics supply on the quality of life and nutritional status of elderly hemodialysis patients. Participants will be devided into intervention group and placebo group in an 1:1 ratio.They will: 1. In the treatment period for 12 weeks, intervention group receives postbiotics product while the other group receives placebo. 2. In the subsequent 12 weeks, intervention group ends the trial and placebo group enters into remedial treatment period. Placebo group will receive postbiotics product for 12 weeks. Researchers will analyze the change of indicators such as quality of life and nutrition state of participants from the baseline to end of treatment, and compare the difference between the two group.
CONDITIONS
Official Title
Effect of the Postbiotics on Complications Treatment in Elderly Hemodialysis Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 65 years or older
- Receiving maintenance hemodialysis therapy for at least 6 months
You will not qualify if you...
- Medical history affecting oral feeding within the last month (e.g., intestinal obstruction, gastrointestinal bleeding, acute pancreatitis, accidental inhalation)
- Medical history affecting gastrointestinal functions (e.g., inflammatory bowel disease, irritable bowel syndrome, short bowel syndrome)
- Inability to communicate and cooperate normally
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking UFH
Beijing, Beijing Municipality, China, 100034
Actively Recruiting
Research Team
Y
Yuqing Chen
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here